{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T00:59:34Z","timestamp":1784768374356,"version":"3.55.0"},"publisher-location":"Singapore","reference-count":139,"publisher":"Springer Singapore","isbn-type":[{"value":"9789811335396","type":"print"},{"value":"9789811335402","type":"electronic"}],"license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019]]},"DOI":"10.1007\/978-981-13-3540-2_5","type":"book-chapter","created":{"date-parts":[[2019,5,7]],"date-time":"2019-05-07T15:34:50Z","timestamp":1557243290000},"page":"85-101","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["The Roles of Apolipoprotein E, Lipids, and Glucose in the Pathogenesis of Alzheimer\u2019s Disease"],"prefix":"10.1007","author":[{"given":"Mitsuru","family":"Shinohara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoyuki","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,5,7]]},"reference":[{"key":"5_CR1","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1016\/j.jalz.2015.12.006","volume":"12","author":"EL Abner","year":"2016","unstructured":"Abner EL, Nelson PT, Kryscio RJ, Schmitt FA, Fardo DW, Woltjer RL, Cairns NJ, Yu L, Dodge HH, Xiong C, Masaki K, Tyas SL, Bennett DA, Schneider JA, Arvanitakis Z (2016) Diabetes is associated with cerebrovascular but not Alzheimer\u2019s disease neuropathology. Alzheimers Dement 12:882\u2013889","journal-title":"Alzheimers Dement"},{"key":"5_CR2","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1007\/978-1-4020-8831-5_9","volume-title":"Lipids in health and disease","author":"RM Adibhatla","year":"2008","unstructured":"Adibhatla RM, Hatcher JF (2008) Altered lipid metabolism in brain injury and disorders. In: Quinn PJ, Wang X (eds) Lipids in health and disease. Springer Netherlands, Dordrecht, pp 241\u2013268"},{"issue":"4","key":"5_CR3","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1001\/jamaneurol.2015.4851","volume":"73","author":"DC Aguirre-Acevedo","year":"2016","unstructured":"Aguirre-Acevedo DC, Lopera F, Henao E, Tirado V, Munoz C, Giraldo M, Bangdiwala SI, Reiman EM, Tariot PN, Langbaum JB, Quiroz YT, Jaimes F (2016) Cognitive decline in a Colombian kindred with autosomal dominant Alzheimer disease: a retrospective cohort study. JAMA Neurol 73(4):431\u2013438","journal-title":"JAMA Neurol"},{"issue":"1","key":"5_CR4","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1038\/jcbfm.2014.172","volume":"35","author":"W Alata","year":"2015","unstructured":"Alata W, Ye Y, St-Amour I, Vandal M, Calon F (2015) Human apolipoprotein E \u025b4 expression impairs cerebral vascularization and blood\u2013brain barrier function in mice. J Cereb Blood Flow Metab 35(1):86\u201394","journal-title":"J Cereb Blood Flow Metab"},{"issue":"5","key":"5_CR5","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1097\/01.JGP.0000310778.20870.ae","volume":"16","author":"KJ Anstey","year":"2008","unstructured":"Anstey KJ, Lipnicki DM, Low LF (2008) Cholesterol as a risk factor for dementia and cognitive decline: a systematic review of prospective studies with meta-analysis. Am J Geriatr Psychiatry 16(5):343\u2013354","journal-title":"Am J Geriatr Psychiatry"},{"issue":"11","key":"5_CR6","doi-asserted-by":"publisher","first-page":"1960","DOI":"10.1212\/01.wnl.0000247053.45483.4e","volume":"67","author":"Z Arvanitakis","year":"2006","unstructured":"Arvanitakis Z, Schneider JA, Wilson RS, Li Y, Arnold SE, Wang Z, Bennett DA (2006) Diabetes is related to cerebral infarction but not to AD pathology in older persons. Neurology 67(11):1960\u20131965","journal-title":"Neurology"},{"issue":"8","key":"5_CR7","doi-asserted-by":"publisher","first-page":"1996","DOI":"10.1016\/j.neurobiolaging.2013.02.003","volume":"34","author":"J Barnes","year":"2013","unstructured":"Barnes J, Carmichael OT, Leung KK, Schwarz C, Ridgway GR, Bartlett JW, Malone IB, Schott JM, Rossor MN, Biessels GJ, DeCarli C, Fox NC (2013) Vascular and Alzheimer\u2019s disease markers independently predict brain atrophy rate in Alzheimer\u2019s disease neuroimaging initiative controls. Neurobiol Aging 34(8):1996\u20132002","journal-title":"Neurobiol Aging"},{"issue":"1\u20132","key":"5_CR8","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/S0006-8993(99)01894-6","volume":"843","author":"U Beffert","year":"1999","unstructured":"Beffert U, Cohn JS, Petit-Turcotte C, Tremblay M, Aumont N, Ramassamy C, Davignon J, Poirier J (1999) Apolipoprotein E and beta-amyloid levels in the hippocampus and frontal cortex of Alzheimer\u2019s disease subjects are disease-related and apolipoprotein E genotype dependent. Brain Res 843(1\u20132):87\u201394","journal-title":"Brain Res"},{"issue":"7399","key":"5_CR9","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1038\/nature11087","volume":"485","author":"RD Bell","year":"2012","unstructured":"Bell RD, Winkler EA, Singh I, Sagare AP, Deane R, Wu Z, Holtzman DM, Betsholtz C, Armulik A, Sallstrom J, Berk BC, Zlokovic BV (2012) Apolipoprotein E controls cerebrovascular integrity via cyclophilin A. Nature 485(7399):512\u2013516","journal-title":"Nature"},{"issue":"9","key":"5_CR10","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1212\/01.wnl.0000343853.00346.a4","volume":"72","author":"DJ Berlau","year":"2009","unstructured":"Berlau DJ, Corrada MM, Head E, Kawas CH (2009) APOE epsilon2 is associated with intact cognition but increased Alzheimer pathology in the oldest old. Neurology 72(9):829\u2013834","journal-title":"Neurology"},{"issue":"3","key":"5_CR11","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1097\/NEN.0b013e31819ac3cb","volume":"68","author":"M Boimel","year":"2009","unstructured":"Boimel M, Grigoriadis N, Lourbopoulos A, Touloumi O, Rosenmann D, Abramsky O, Rosenmann H (2009) Statins reduce the neurofibrillary tangle burden in a mouse model of tauopathy. J Neuropathol Exp Neurol 68(3):314\u2013325","journal-title":"J Neuropathol Exp Neurol"},{"issue":"5","key":"5_CR12","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1038\/nrn2620","volume":"10","author":"G Bu","year":"2009","unstructured":"Bu G (2009) Apolipoprotein E and its receptors in Alzheimer\u2019s disease: pathways, pathogenesis and therapy. Nat Rev Neurosci 10(5):333\u2013344","journal-title":"Nat Rev Neurosci"},{"issue":"1","key":"5_CR13","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/S1474-4422(08)70271-0","volume":"8","author":"A Burns","year":"2009","unstructured":"Burns A (2009) Alzheimer\u2019s disease: on the verges of treatment and prevention. Lancet Neurol 8(1):4\u20135","journal-title":"Lancet Neurol"},{"issue":"9","key":"5_CR14","doi-asserted-by":"publisher","first-page":"1856","DOI":"10.2337\/diabetes.48.9.1856","volume":"48","author":"AE Caballero","year":"1999","unstructured":"Caballero AE, Arora S, Saouaf R, Lim SC, Smakowski P, Park JY, King GL, LoGerfo FW, Horton ES, Veves A (1999) Microvascular and macrovascular reactivity is reduced in subjects at risk for type 2 diabetes. Diabetes 48(9):1856\u20131862","journal-title":"Diabetes"},{"key":"5_CR15","doi-asserted-by":"publisher","first-page":"13842","DOI":"10.1038\/srep13842","volume":"5","author":"ES Chan","year":"2015","unstructured":"Chan ES, Chen C, Cole GM, Wong B-S (2015) Differential interaction of apolipoprotein-E isoforms with insulin receptors modulates brain insulin signaling in mutant human amyloid precursor protein transgenic mice. Sci Rep 5:13842","journal-title":"Sci Rep"},{"key":"5_CR16","doi-asserted-by":"publisher","first-page":"26119","DOI":"10.1038\/srep26119","volume":"6","author":"ES Chan","year":"2016","unstructured":"Chan ES, Shetty MS, Sajikumar S, Chen C, Soong TW, Wong B-S (2016) ApoE4 expression accelerates hippocampus-dependent cognitive deficits by enhancing A\u03b2 impairment of insulin signaling in an Alzheimer\u2019s disease mouse model. Sci Rep 6:26119","journal-title":"Sci Rep"},{"issue":"6","key":"5_CR17","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1212\/WNL.0000000000002939","volume":"87","author":"L Chang","year":"2016","unstructured":"Chang L, Douet V, Bloss C, Lee K, Pritchett A, Jernigan TL, Akshoomoff N, Murray SS, Frazier J, Kennedy DN, Amaral DG, Gruen J, Kaufmann WE, Casey BJ, Sowell E, Ernst T (2016) Gray matter maturation and cognition in children with different APOE epsilon genotypes. Neurology 87(6):585\u2013594","journal-title":"Neurology"},{"issue":"12","key":"5_CR18","doi-asserted-by":"publisher","first-page":"3320","DOI":"10.2337\/db06-0485","volume":"55","author":"BJ Clodfelder-Miller","year":"2006","unstructured":"Clodfelder-Miller BJ, Zmijewska AA, Johnson GV, Jope RS (2006) Tau is hyperphosphorylated at multiple sites in mouse brain in vivo after streptozotocin-induced insulin deficiency. Diabetes 55(12):3320\u20133325","journal-title":"Diabetes"},{"issue":"6559","key":"5_CR19","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1038\/378785a0","volume":"378","author":"DAE Cross","year":"1995","unstructured":"Cross DAE, Alessi DR, Cohen P, Andjelkovich M, Hemmings BA (1995) Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature 378(6559):785\u2013789","journal-title":"Nature"},{"issue":"1","key":"5_CR20","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1002\/msj.20155","volume":"77","author":"DL Dickstein","year":"2010","unstructured":"Dickstein DL, Walsh J, Brautigam H, Stockton SD, Gandy S, Hof PR (2010) Role of vascular risk factors and vascular dysfunction in Alzheimer\u2019s disease. Mt Sinai J Med: J Transl Personalized Med 77(1):82\u2013102","journal-title":"Mt Sinai J Med: J Transl Personalized Med"},{"key":"5_CR21","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.nbd.2016.01.005","volume":"88","author":"NB Khoury El","year":"2016","unstructured":"El Khoury NB, Gratuze M, Petry F, Papon MA, Julien C, Marcouiller F, Morin F, Nicholls SB, Calon F, Hebert SS, Marette A, Planel E (2016) Hypothermia mediates age-dependent increase of tau phosphorylation in db\/db mice. Neurobiol Dis 88:55\u201365","journal-title":"Neurobiol Dis"},{"issue":"11","key":"5_CR22","doi-asserted-by":"publisher","first-page":"2803","DOI":"10.1523\/JNEUROSCI.5170-04.2005","volume":"25","author":"JD Fryer","year":"2005","unstructured":"Fryer JD, Simmons K, Parsadanian M, Bales KR, Paul SM, Sullivan PM, Holtzman DM (2005) Human apolipoprotein E4 alters the amyloid-beta 40:42 ratio and promotes the formation of cerebral amyloid angiopathy in an amyloid precursor protein transgenic model. J Neurosci 25(11):2803\u20132810","journal-title":"J Neurosci"},{"issue":"2","key":"5_CR23","doi-asserted-by":"publisher","first-page":"375","DOI":"10.3233\/JAD-131736","volume":"40","author":"N Garcia-Casares","year":"2014","unstructured":"Garcia-Casares N, Berthier ML, Jorge RE, Gonzalez-Alegre P, Gutierrez Cardo A, Rioja Villodres J, Acion L, Ariza Corbo MJ, Nabrozidis A, Garcia-Arnes JA, Gonzalez-Santos P (2014) Structural and functional brain changes in middle-aged type 2 diabetic patients: a cross-sectional study. J Alzheimers Dis 40(2):375\u2013386","journal-title":"J Alzheimers Dis"},{"issue":"9","key":"5_CR24","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1097\/NEN.0000000000000103","volume":"73","author":"F Glockner","year":"2014","unstructured":"Glockner F, Ohm TG (2014) Tau pathology induces intraneuronal cholesterol accumulation. J Neuropathol Exp Neurol 73(9):846\u2013854","journal-title":"J Neuropathol Exp Neurol"},{"key":"5_CR25","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.neurobiolaging.2016.07.016","volume":"47","author":"M Gratuze","year":"2016","unstructured":"Gratuze M, Julien J, Morin F, Calon F, Hebert SS, Marette A, Planel E (2016) High-fat, high-sugar, and high-cholesterol consumption does not impact tau pathogenesis in a mouse model of Alzheimer\u2019s disease-like tau pathology. Neurobiol Aging 47:71\u201373","journal-title":"Neurobiol Aging"},{"issue":"1","key":"5_CR26","doi-asserted-by":"publisher","first-page":"196 e113","DOI":"10.1016\/j.neurobiolaging.2010.05.026","volume":"33","author":"M Guglielmotto","year":"2012","unstructured":"Guglielmotto M, Aragno M, Tamagno E, Vercellinatto I, Visentin S, Medana C, Catalano MG, Smith MA, Perry G, Danni O, Boccuzzi G, Tabaton M (2012) AGEs\/RAGE complex upregulates BACE1 via NF-kappaB pathway activation. Neurobiol Aging 33(1):196 e113\u2013196 e127","journal-title":"Neurobiol Aging"},{"key":"5_CR27","doi-asserted-by":"publisher","first-page":"29396","DOI":"10.1038\/srep29396","volume":"6","author":"C Guo","year":"2016","unstructured":"Guo C, Zhang S, Li JY, Ding C, Yang ZH, Chai R, Wang X, Wang ZY (2016) Chronic hyperglycemia induced via the heterozygous knockout of Pdx1 worsens neuropathological lesion in an Alzheimer mouse model. Sci Rep 6:29396","journal-title":"Sci Rep"},{"issue":"3","key":"5_CR28","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/0304-3940(96)12348-X","volume":"204","author":"EL Helkala","year":"1996","unstructured":"Helkala EL, Koivisto K, Hanninen T, Vanhanen M, Kervinen K, Kuusisto J, Mykkanen L, Kesaniemi YA, Laakso M, Riekkinen P Sr (1996) Memory functions in human subjects with different apolipoprotein E phenotypes during a 3-year population-based follow-up study. Neurosci Lett 204(3):177\u2013180","journal-title":"Neurosci Lett"},{"issue":"2","key":"5_CR29","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1002\/ana.24439","volume":"78","author":"MT Heneka","year":"2015","unstructured":"Heneka MT, Fink A, Doblhammer G (2015) Effect of pioglitazone medication on the incidence of dementia. Ann Neurol 78(2):284\u2013294","journal-title":"Ann Neurol"},{"key":"5_CR30","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.2337\/dc15-2800","volume":"39","author":"N Hirabayashi","year":"2016","unstructured":"Hirabayashi N, Hata J, Ohara T, Mukai N, Nagata M, Shibata M, Gotoh S, Furuta Y, Yamashita F, Yoshihara K, Kitazono T, Sudo N, Kiyohara Y, Ninomiya T (2016) Association between diabetes and hippocampal atrophy in elderly Japanese: the Hisayama study. Diabetes Care 39:1543\u20131549","journal-title":"Diabetes Care"},{"issue":"7","key":"5_CR31","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1096\/fj.03-0978fje","volume":"18","author":"L Ho","year":"2004","unstructured":"Ho L, Qin W, Pompl PN, Xiang Z, Wang J, Zhao Z, Peng Y, Cambareri G, Rocher A, Mobbs CV, Hof PR, Pasinetti GM (2004) Diet-induced insulin resistance promotes amyloidosis in a transgenic mouse model of Alzheimer\u2019s disease. FASEB J: Offl Publ Fed Am Soc Exp Biol 18(7):902\u2013904","journal-title":"FASEB J: Offl Publ Fed Am Soc Exp Biol"},{"issue":"2","key":"5_CR32","doi-asserted-by":"publisher","first-page":"180","DOI":"10.2337\/diacare.6.2.180","volume":"6","author":"CS Holmes","year":"1983","unstructured":"Holmes CS, Hayford JT, Gonzalez JL, Weydert JA (1983) A survey of cognitive functioning at difference glucose levels in diabetic persons. Diabetes Care 6(2):180\u2013185","journal-title":"Diabetes Care"},{"issue":"6","key":"5_CR33","first-page":"015","volume":"10","author":"J Hu","year":"2015","unstructured":"Hu J, Liu CC, Chen XF, Zhang YW, Xu H, Bu G (2015) Opposing effects of viral mediated brain expression of apolipoprotein E2 (apoE2) and apoE4 on apoE lipidation and Abeta metabolism in apoE4-targeted replacement mice. Mol Neurodegener 10(6):015\u20130001","journal-title":"Mol Neurodegener"},{"issue":"4","key":"5_CR34","doi-asserted-by":"publisher","first-page":"891","DOI":"10.3233\/JAD-2012-121585","volume":"33","author":"TM Hughes","year":"2013","unstructured":"Hughes TM, Rosano C, Evans RW, Kuller LH (2013) Brain cholesterol metabolism, oxysterols, and dementia. J Alzheimers Dis 33(4):891\u2013911","journal-title":"J Alzheimers Dis"},{"issue":"1","key":"5_CR35","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1002\/ana.410400111","volume":"40","author":"BT Hyman","year":"1996","unstructured":"Hyman BT, Gomez-Isla T, Briggs M, Chung H, Nichols S, Kohout F, Wallace R (1996) Apolipoprotein E and cognitive change in an elderly population. Ann Neurol 40(1):55\u201366","journal-title":"Ann Neurol"},{"issue":"3 suppl 1","key":"5_CR36","first-page":"S40","volume":"40","author":"C Iadecola","year":"2009","unstructured":"Iadecola C, Park L, Capone C (2009) Threats to the mind. Aging, Amyloid Hypertens 40(3 suppl 1):S40\u2013S44","journal-title":"Aging, Amyloid Hypertens"},{"issue":"1\u20133","key":"5_CR37","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1007\/BF02816111","volume":"9","author":"K Iqbal","year":"1994","unstructured":"Iqbal K, Alonso AC, Gong CX, Khatoon S, Singh TJ, Grundke-Iqbal I (1994) Mechanism of neurofibrillary degeneration in Alzheimer\u2019s disease. Mol Neurobiol 9(1\u20133):119\u2013123","journal-title":"Mol Neurobiol"},{"issue":"1","key":"5_CR38","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/s00401-009-0486-3","volume":"118","author":"K Iqbal","year":"2009","unstructured":"Iqbal K, Liu F, Gong CX, Alonso Adel C, Grundke-Iqbal I (2009) Mechanisms of tau-induced neurodegeneration. Acta Neuropathol 118(1):53\u201369","journal-title":"Acta Neuropathol"},{"issue":"7376","key":"5_CR39","doi-asserted-by":"publisher","first-page":"E4","DOI":"10.1038\/nature10615","volume":"480","author":"T Jaworski","year":"2011","unstructured":"Jaworski T, Dewachter I, Lechat B, Gees M, Kremer A, Demedts D, Borghgraef P, Devijver H, Kugler S, Patel S, Woodgett JR, Van Leuven F (2011) GSK-3alpha\/beta kinases and amyloid production in vivo. Nature 480(7376):E4\u2013E5. discussion E6","journal-title":"Nature"},{"issue":"15","key":"5_CR40","doi-asserted-by":"publisher","first-page":"3265","DOI":"10.1002\/jnr.21787","volume":"86","author":"CG Jolivalt","year":"2008","unstructured":"Jolivalt CG, Lee CA, Beiswenger KK, Smith JL, Orlov M, Torrance MA, Masliah E (2008) Defective insulin signaling pathway and increased glycogen synthase kinase-3 activity in the brain of diabetic mice: parallels with Alzheimer\u2019s disease and correction by insulin. J Neurosci Res 86(15):3265\u20133274","journal-title":"J Neurosci Res"},{"issue":"6","key":"5_CR41","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1038\/nrneurol.2009.72","volume":"5","author":"RN Kalaria","year":"2009","unstructured":"Kalaria RN (2009) Neurodegenerative disease: diabetes, microvascular pathology and Alzheimer disease. Nat Rev Neurol 5(6):305\u2013306","journal-title":"Nat Rev Neurol"},{"issue":"4","key":"5_CR42","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1212\/WNL.0b013e31824365ab","volume":"78","author":"K Kantarci","year":"2012","unstructured":"Kantarci K, Lowe V, Przybelski SA, Weigand SD, Senjem ML, Ivnik RJ, Preboske GM, Roberts R, Geda YE, Boeve BF, Knopman DS, Petersen RC, Jack CR Jr (2012) APOE modifies the association between Abeta load and cognition in cognitively normal older adults. Neurology 78(4):232\u2013240","journal-title":"Neurology"},{"issue":"5","key":"5_CR43","doi-asserted-by":"publisher","first-page":"438","DOI":"10.2174\/156720508785908919","volume":"5","author":"FN Karen","year":"2008","unstructured":"Karen FN, Leonel R, Leonardo PN, Gonzalo F, Paula R, Ricardo BM (2008) Insulin resistance and Alzheimers disease: molecular links & clinical implications. Curr Alzheimer Res 5(5):438\u2013447","journal-title":"Curr Alzheimer Res"},{"issue":"11","key":"5_CR44","doi-asserted-by":"publisher","first-page":"e7917","DOI":"10.1371\/journal.pone.0007917","volume":"4","author":"YD Ke","year":"2009","unstructured":"Ke YD, Delerue F, Gladbach A, Gotz J, Ittner LM (2009) Experimental diabetes mellitus exacerbates tau pathology in a transgenic mouse model of Alzheimer\u2019s disease. PLoS One 4(11):e7917","journal-title":"PLoS One"},{"issue":"2","key":"5_CR45","doi-asserted-by":"publisher","first-page":"411","DOI":"10.3233\/JAD-150348","volume":"48","author":"JT Keeney","year":"2015","unstructured":"Keeney JT, Ibrahimi S, Zhao L (2015) Human ApoE isoforms differentially modulate glucose and amyloid metabolic pathways in female brain: evidence of the mechanism of neuroprotection by ApoE2 and implications for Alzheimer\u2019s disease prevention and early intervention. J Alzheimers Dis 48(2):411\u2013424","journal-title":"J Alzheimers Dis"},{"issue":"20","key":"5_CR46","doi-asserted-by":"publisher","first-page":"1746","DOI":"10.1212\/01.wnl.0000435561.00234.ee","volume":"81","author":"L Kerti","year":"2013","unstructured":"Kerti L, Witte AV, Winkler A, Grittner U, Rujescu D, Floel A (2013) Higher glucose levels associated with lower memory and reduced hippocampal microstructure. Neurology 81(20):1746\u20131752","journal-title":"Neurology"},{"issue":"12","key":"5_CR47","doi-asserted-by":"publisher","first-page":"5294","DOI":"10.1210\/en.2009-0695","volume":"150","author":"B Kim","year":"2009","unstructured":"Kim B, Backus C, Oh S, Hayes JM, Feldman EL (2009) Increased tau phosphorylation and cleavage in mouse models of type 1 and type 2 diabetes. Endocrinology 150(12):5294\u20135301","journal-title":"Endocrinology"},{"issue":"49","key":"5_CR48","doi-asserted-by":"publisher","first-page":"18007","DOI":"10.1523\/JNEUROSCI.3773-11.2011","volume":"31","author":"J Kim","year":"2011","unstructured":"Kim J, Jiang H, Park S, Eltorai AE, Stewart FR, Yoon H, Basak JM, Finn MB, Holtzman DM (2011) Haploinsufficiency of human APOE reduces amyloid deposition in a mouse model of amyloid-beta amyloidosis. J Neurosci 31(49):18007\u201318012","journal-title":"J Neurosci"},{"issue":"9","key":"5_CR49","doi-asserted-by":"publisher","first-page":"2096","DOI":"10.1016\/j.neurobiolaging.2014.03.006","volume":"35","author":"DS Knopman","year":"2014","unstructured":"Knopman DS, Jack CR Jr, Wiste HJ, Lundt ES, Weigand SD, Vemuri P, Lowe VJ, Kantarci K, Gunter JL, Senjem ML, Mielke MM, Roberts RO, Boeve BF, Petersen RC (2014) 18F-fluorodeoxyglucose positron emission tomography, aging, and apolipoprotein E genotype in cognitively normal persons. Neurobiol Aging 35(9):2096\u20132106","journal-title":"Neurobiol Aging"},{"issue":"4","key":"5_CR50","doi-asserted-by":"publisher","first-page":"677","DOI":"10.3233\/JAD-2009-1011","volume":"16","author":"D Kopf","year":"2009","unstructured":"Kopf D, Frolich L (2009) Risk of incident Alzheimer\u2019s disease in diabetic patients: a systematic review of prospective trials. J Alzheimers Dis 16(4):677\u2013685","journal-title":"J Alzheimers Dis"},{"issue":"4","key":"5_CR51","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1001\/archneurol.2010.30","volume":"67","author":"JS Langbaum","year":"2010","unstructured":"Langbaum JS, Chen K, Caselli RJ et al (2010) Hypometabolism in alzheimer-affected brain regions in cognitively healthy latino individuals carrying the apolipoprotein e \u03b54 allele. Arch Neurol 67(4):462\u2013468","journal-title":"Arch Neurol"},{"issue":"1","key":"5_CR52","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.plipres.2011.11.004","volume":"51","author":"MD Ledesma","year":"2012","unstructured":"Ledesma MD, Martin MG, Dotti CG (2012) Lipid changes in the aged brain: effect on synaptic function and neuronal survival. Prog Lipid Res 51(1):23\u201335","journal-title":"Prog Lipid Res"},{"key":"5_CR53","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1212\/WNL.0000000000002950","volume":"87","author":"W Li","year":"2016","unstructured":"Li W, Risacher SL, Huang E, Saykin AJ (2016) Type 2 diabetes mellitus is associated with brain atrophy and hypometabolism in the ADNI cohort. Neurology 87:595\u2013600","journal-title":"Neurology"},{"issue":"1","key":"5_CR54","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1111\/j.1471-4159.2009.06320.x","volume":"111","author":"Y Liu","year":"2009","unstructured":"Liu Y, Liu F, Grundke-Iqbal I, Iqbal K, Gong CX (2009) Brain glucose transporters, O-GlcNAcylation and phosphorylation of tau in diabetes and Alzheimer\u2019s disease. J Neurochem 111(1):242\u2013249","journal-title":"J Neurochem"},{"issue":"1","key":"5_CR55","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1002\/path.2912","volume":"225","author":"Y Liu","year":"2011","unstructured":"Liu Y, Liu F, Grundke-Iqbal I, Iqbal K, Gong C-X (2011) Deficient brain insulin signalling pathway in Alzheimer\u2019s disease and diabetes. J Pathol 225(1):54\u201362","journal-title":"J Pathol"},{"issue":"2","key":"5_CR56","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1038\/nrneurol.2012.263","volume":"9","author":"CC Liu","year":"2013","unstructured":"Liu CC, Kanekiyo T, Xu H, Bu G (2013) Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy. Nat Rev Neurol 9(2):106\u2013118","journal-title":"Nat Rev Neurol"},{"issue":"14","key":"5_CR57","first-page":"1864","volume":"123","author":"F Lu","year":"2010","unstructured":"Lu F, Li X, Suo AQ, Zhang JW (2010) Inhibition of tau hyperphosphorylation and beta amyloid production in rat brain by oral administration of atorvastatin. Chin Med J 123(14):1864\u20131870","journal-title":"Chin Med J"},{"key":"5_CR58","doi-asserted-by":"publisher","first-page":"2463","DOI":"10.1172\/JCI79742","volume":"125","author":"SL Macauley","year":"2015","unstructured":"Macauley SL, Stanley M, Caesar EE, Yamada SA, Raichle ME, Perez R, Mahan TE, Sutphen CL, Holtzman DM (2015) Hyperglycemia modulates extracellular amyloid-beta concentrations and neuronal activity in vivo. J Clin Invest 125:2463\u20132467","journal-title":"J Clin Invest"},{"issue":"3","key":"5_CR59","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.arcmed.2010.03.007","volume":"41","author":"RB Maccioni","year":"2010","unstructured":"Maccioni RB, Farias G, Morales I, Navarrete L (2010) The revitalized tau hypothesis on Alzheimer\u2019s disease. Arch Med Res 41(3):226\u2013231","journal-title":"Arch Med Res"},{"issue":"5","key":"5_CR60","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1586\/ern.09.18","volume":"9","author":"PA Maher","year":"2009","unstructured":"Maher PA, Schubert DR (2009) Metabolic links between diabetes and Alzheimer\u2019s disease. Expert Rev Neurother 9(5):617\u2013630","journal-title":"Expert Rev Neurother"},{"issue":"1","key":"5_CR61","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.neuron.2013.02.003","volume":"78","author":"G Mairet-Coello","year":"2013","unstructured":"Mairet-Coello G, Courchet J, Pieraut S, Courchet V, Maximov A, Polleux F (2013) The CAMKK2-AMPK kinase pathway mediates the synaptotoxic effects of Abeta oligomers through Tau phosphorylation. Neuron 78(1):94\u2013108","journal-title":"Neuron"},{"key":"5_CR62","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/1750-1326-9-60","volume":"9","author":"C Marquer","year":"2014","unstructured":"Marquer C, Laine J, Dauphinot L, Hanbouch L, Lemercier-Neuillet C, Pierrot N, Bossers K, Le M, Corlier F, Benstaali C, Saudou F, Thinakaran G, Cartier N, Octave JN, Duyckaerts C, Potier MC (2014) Increasing membrane cholesterol of neurons in culture recapitulates Alzheimer\u2019s disease early phenotypes. Mol Neurodegener 9:60","journal-title":"Mol Neurodegener"},{"issue":"9","key":"5_CR63","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1212\/WNL.0b013e3181eee25f","volume":"75","author":"T Matsuzaki","year":"2010","unstructured":"Matsuzaki T, Sasaki K, Tanizaki Y, Hata J, Fujimi K, Matsui Y, Sekita A, Suzuki SO, Kanba S, Kiyohara Y, Iwaki T (2010) Insulin resistance is associated with the pathology of Alzheimer disease: the Hisayama study. Neurology 75(9):764\u2013770","journal-title":"Neurology"},{"issue":"11","key":"5_CR64","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1212\/WNL.0b013e31822e145d","volume":"77","author":"T Matsuzaki","year":"2011","unstructured":"Matsuzaki T, Sasaki K, Hata J, Hirakawa Y, Fujimi K, Ninomiya T, Suzuki SO, Kanba S, Kiyohara Y, Iwaki T (2011) Association of Alzheimer disease pathology with abnormal lipid metabolism: the Hisayama study. Neurology 77(11):1068\u20131075","journal-title":"Neurology"},{"issue":"5545","key":"5_CR65","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1126\/science.294.5545.1354","volume":"294","author":"DH Mauch","year":"2001","unstructured":"Mauch DH, Nagler K, Schumacher S, Goritz C, Muller EC, Otto A, Pfrieger FW (2001) CNS synaptogenesis promoted by glia-derived cholesterol. Science 294(5545):1354\u20131357","journal-title":"Science"},{"key":"5_CR66","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1111\/j.1600-0404.2006.00681.x","volume":"185","author":"M Michikawa","year":"2006","unstructured":"Michikawa M (2006) Role of cholesterol in amyloid cascade: cholesterol-dependent modulation of tau phosphorylation and mitochondrial function. Acta Neurol Scand Suppl 185:21\u201326","journal-title":"Acta Neurol Scand Suppl"},{"issue":"10","key":"5_CR67","doi-asserted-by":"publisher","first-page":"2981","DOI":"10.2337\/dc13-0229","volume":"36","author":"EM Moore","year":"2013","unstructured":"Moore EM, Mander AG, Ames D, Kotowicz MA, Carne RP, Brodaty H, Woodward M, Boundy K, Ellis KA, Bush AI, Faux NG, Martins R, Szoeke C, Rowe C, Watters DA (2013) Increased risk of cognitive impairment in patients with diabetes is associated with metformin. Diabetes Care 36(10):2981\u20132987","journal-title":"Diabetes Care"},{"issue":"15","key":"5_CR68","doi-asserted-by":"publisher","first-page":"4248","DOI":"10.1523\/JNEUROSCI.4640-14.2016","volume":"36","author":"J Morales-Corraliza","year":"2016","unstructured":"Morales-Corraliza J, Wong H, Mazzella MJ, Che S, Lee SH, Petkova E, Wagner JD, Hemby SE, Ginsberg SD, Mathews PM (2016) Brain-wide insulin resistance, tau phosphorylation changes, and hippocampal Neprilysin and amyloid-beta alterations in a monkey model of type 1 diabetes. J Neurosci 36(15):4248\u20134258","journal-title":"J Neurosci"},{"issue":"12","key":"5_CR69","doi-asserted-by":"publisher","first-page":"4036","DOI":"10.2337\/dc13-0143","volume":"36","author":"C Moran","year":"2013","unstructured":"Moran C, Phan TG, Chen J, Blizzard L, Beare R, Venn A, Munch G, Wood AG, Forbes J, Greenaway TM, Pearson S, Srikanth V (2013) Brain atrophy in type 2 diabetes: regional distribution and influence on cognition. Diabetes Care 36(12):4036\u20134042","journal-title":"Diabetes Care"},{"issue":"3","key":"5_CR70","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1016\/j.neurobiolaging.2013.09.033","volume":"35","author":"JK Morris","year":"2014","unstructured":"Morris JK, Vidoni ED, Honea RA, Burns JM (2014) Impaired glycemia increases disease progression in mild cognitive impairment. Neurobiol Aging 35(3):585\u2013589","journal-title":"Neurobiol Aging"},{"issue":"12","key":"5_CR71","first-page":"3082","volume":"32","author":"DMJ Muris","year":"2012","unstructured":"Muris DMJ, Houben AJHM, Schram MT, Stehouwer CDA (2012) Microvascular dysfunction is associated with a higher incidence of type 2 diabetes mellitus. Syst Rev Meta-Analysis 32(12):3082\u20133094","journal-title":"Syst Rev Meta-Analysis"},{"issue":"1","key":"5_CR72","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1093\/brain\/awt318","volume":"137","author":"JH Neltner","year":"2014","unstructured":"Neltner JH, Abner EL, Baker S, Schmitt FA, Kryscio RJ, Jicha GA, Smith CD, Hammack E, Kukull WA, Brenowitz WD, Van Eldik LJ, Nelson PT (2014) Arteriolosclerosis that affects multiple brain regions is linked to hippocampal sclerosis of ageing. Brain 137(1):255\u2013267","journal-title":"Brain"},{"issue":"1","key":"5_CR73","doi-asserted-by":"publisher","first-page":"61","DOI":"10.3233\/JAD-131901","volume":"41","author":"TP Ng","year":"2014","unstructured":"Ng TP, Feng L, Yap KB, Lee TS, Tan CH, Winblad B (2014) Long-term metformin usage and cognitive function among older adults with diabetes. J Alzheimers Dis 41(1):61\u201368","journal-title":"J Alzheimers Dis"},{"key":"5_CR74","doi-asserted-by":"publisher","first-page":"2255","DOI":"10.1016\/S0140-6736(15)60461-5","volume":"385","author":"T Ngandu","year":"2015","unstructured":"Ngandu T, Lehtisalo J, Solomon A, Levalahti E, Ahtiluoto S, Antikainen R, Backman L, Hanninen T, Jula A, Laatikainen T, Lindstrom J, Mangialasche F, Paajanen T, Pajala S, Peltonen M, Rauramaa R, Stigsdotter-Neely A, Strandberg T, Tuomilehto J, Soininen H, Kivipelto M (2015) A 2 year multidomain intervention of diet, exercise, cognitive training, and vascular risk monitoring versus control to prevent cognitive decline in at-risk elderly people (FINGER): a randomised controlled trial. Lancet 385:2255\u20132263","journal-title":"Lancet"},{"issue":"20","key":"5_CR75","doi-asserted-by":"publisher","first-page":"17536","DOI":"10.1074\/jbc.M111.225532","volume":"286","author":"K Nishitsuji","year":"2011","unstructured":"Nishitsuji K, Hosono T, Nakamura T, Bu G, Michikawa M (2011) Apolipoprotein E regulates the integrity of tight junctions in an isoform-dependent manner in an in vitro blood-brain barrier model. J Biol Chem 286(20):17536\u201317542","journal-title":"J Biol Chem"},{"key":"5_CR76","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1111\/j.1600-0404.2006.00692.x","volume":"185","author":"TG Ohm","year":"2006","unstructured":"Ohm TG, Meske V (2006) Cholesterol, statins and tau. Acta Neurol Scand Suppl 185:93\u2013101","journal-title":"Acta Neurol Scand Suppl"},{"issue":"3","key":"5_CR77","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1007\/s004010051080","volume":"98","author":"TG Ohm","year":"1999","unstructured":"Ohm TG, Scharnagl H, Marz W, Bohl J (1999) Apolipoprotein E isoforms and the development of low and high Braak stages of Alzheimer\u2019s disease-related lesions. Acta Neuropathol 98(3):273\u2013280","journal-title":"Acta Neuropathol"},{"key":"5_CR78","doi-asserted-by":"publisher","first-page":"3754","DOI":"10.1038\/srep03754","volume":"4","author":"Q-R Ong","year":"2014","unstructured":"Ong Q-R, Chan ES, Lim M-L, Cole GM, Wong B-S (2014) Reduced phosphorylation of brain insulin receptor substrate and Akt proteins in apolipoprotein-E4 targeted replacement mice. Sci Rep 4:3754","journal-title":"Sci Rep"},{"issue":"20","key":"5_CR79","doi-asserted-by":"publisher","first-page":"1768","DOI":"10.1212\/WNL.0000000000000432","volume":"82","author":"R Ossenkoppele","year":"2014","unstructured":"Ossenkoppele R, van der Flier WM, Verfaillie SCJ, Vrenken H, Versteeg A, van Schijndel RA, Sikkes SA, Twisk J, Adriaanse SM, Zwan MD, Boellaard R, Windhorst AD, Barkhof F, Scheltens P, Lammertsma AA, van Berckel BNM (2014) Long-term effects of amyloid, hypometabolism, and atrophy on neuropsychological functions. Neurology 82(20):1768\u20131775","journal-title":"Neurology"},{"issue":"9","key":"5_CR80","doi-asserted-by":"publisher","first-page":"1937","DOI":"10.1212\/WNL.53.9.1937","volume":"53","author":"A Ott","year":"1999","unstructured":"Ott A, Stolk RP, van Harskamp F, Pols HAP, Hofman A, Breteler MMB (1999) Diabetes mellitus and the risk of dementia: the Rotterdam study. Neurology 53(9):1937","journal-title":"Neurology"},{"issue":"5","key":"5_CR81","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/S1262-3636(07)70298-7","volume":"32","author":"F Pasquier","year":"2006","unstructured":"Pasquier F, Boulogne A, Leys D, Fontaine P (2006) Diabetes mellitus and dementia. Diabetes Metab 32(5):403\u2013414","journal-title":"Diabetes Metab"},{"issue":"6938","key":"5_CR82","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1038\/nature01640","volume":"423","author":"CJ Phiel","year":"2003","unstructured":"Phiel CJ, Wilson CA, Lee VM, Klein PS (2003) GSK-3alpha regulates production of Alzheimer\u2019s disease amyloid-beta peptides. Nature 423(6938):435\u2013439","journal-title":"Nature"},{"key":"5_CR83","doi-asserted-by":"publisher","first-page":"906103","DOI":"10.1155\/2014\/906103","volume":"2014","author":"A Pilotto","year":"2014","unstructured":"Pilotto A, Noale M, Maggi S, Addante F, Tiengo A, Perin PC, Rengo G, Crepaldi G (2014) Hypoglycemia is independently associated with multidimensional impairment in elderly diabetic patients. Biomed Res Int 2014:906103","journal-title":"Biomed Res Int"},{"issue":"19","key":"5_CR84","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1056\/NEJM199511093331902","volume":"333","author":"T Polvikoski","year":"1995","unstructured":"Polvikoski T, Sulkava R, Haltia M, Kainulainen K, Vuorio A, Verkkoniemi A, Niinist\u00f6 L, Halonen P, Kontula K (1995) Apolipoprotein E, dementia, and cortical deposition of \u03b2-amyloid protein. N Engl J Med 333(19):1242\u20131248","journal-title":"N Engl J Med"},{"key":"5_CR85","first-page":"1","volume-title":"World Alzheimer report 2016","author":"M Prince","year":"2016","unstructured":"Prince M, Comas-Herrera A, Knapp M, Guerchet MM, Karagiannidou M (2016) World Alzheimer report 2016. Alzheimer\u2019s Disease International, London, pp 1\u2013131"},{"issue":"1","key":"5_CR86","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1097\/WAD.0000000000000172","volume":"31","author":"Jeremy J. Pruzin","year":"2017","unstructured":"Pruzin JJ, Schneider JA, Capuano AW, Leurgans SE, Barnes LL, Ahima RS, Arnold SE, Bennett DA Arvanitakis Z (2017) Diabetes, hemoglobin A1C, and regional Alzheimer disease and infarct pathology. Alzheimer Dis Assoc Disord 31(1):41\u201347","journal-title":"Alzheimer Disease & Associated Disorders"},{"key":"5_CR87","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.brainres.2011.01.084","volume":"1383","author":"Z Qu","year":"2011","unstructured":"Qu Z, Jiao Z, Sun X, Zhao Y, Ren J, Xu G (2011) Effects of streptozotocin-induced diabetes on tau phosphorylation in the rat brain. Brain Res 1383:300\u2013306","journal-title":"Brain Res"},{"key":"5_CR88","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.exger.2016.07.013","volume":"83","author":"MT Redondo","year":"2016","unstructured":"Redondo MT, Beltran-Brotons JL, Reales JM, Ballesteros S (2016) Executive functions in patients with Alzheimer\u2019s disease, type 2 diabetes mellitus patients and cognitively healthy older adults. Exp Gerontol 83:47\u201355","journal-title":"Exp Gerontol"},{"issue":"2","key":"5_CR89","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1001\/jamaneurol.2013.5390","volume":"71","author":"B Reed","year":"2014","unstructured":"Reed B, Villeneuve S, Mack W, DeCarli C, Chui HC, Jagust W (2014) Associations between serum cholesterol levels and cerebral amyloidosis. JAMA Neurol 71(2):195\u2013200","journal-title":"JAMA Neurol"},{"issue":"4","key":"5_CR90","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1006\/nbdi.2000.0304","volume":"7","author":"LM Refolo","year":"2000","unstructured":"Refolo LM, Malester B, LaFrancois J, Bryant-Thomas T, Wang R, Tint GS, Sambamurti K, Duff K, Pappolla MA (2000) Hypercholesterolemia accelerates the Alzheimer\u2019s amyloid pathology in a transgenic mouse model. Neurobiol Dis 7(4):321\u2013331","journal-title":"Neurobiol Dis"},{"issue":"3","key":"5_CR91","doi-asserted-by":"publisher","first-page":"765","DOI":"10.3233\/JAD-2012-121012","volume":"32","author":"F Richard","year":"2012","unstructured":"Richard F, Pasquier F (2012) Can the treatment of vascular risk factors slow cognitive decline in Alzheimer\u2019s disease patients? J Alzheimers Dis 32(3):765\u2013772","journal-title":"J Alzheimers Dis"},{"issue":"45","key":"5_CR92","doi-asserted-by":"publisher","first-page":"11445","DOI":"10.1523\/JNEUROSCI.1972-08.2008","volume":"28","author":"DR Riddell","year":"2008","unstructured":"Riddell DR, Zhou H, Atchison K, Warwick HK, Atkinson PJ, Jefferson J, Xu L, Aschmies S, Kirksey Y, Hu Y, Wagner E, Parratt A, Xu J, Li Z, Zaleska MM, Jacobsen JS, Pangalos MN, Reinhart PH (2008) Impact of apolipoprotein E (ApoE) polymorphism on brain ApoE levels. J Neurosci 28(45):11445\u201311453","journal-title":"J Neurosci"},{"issue":"1","key":"5_CR93","doi-asserted-by":"publisher","first-page":"184","DOI":"10.2337\/dc10-0602","volume":"34","author":"RO Roberts","year":"2011","unstructured":"Roberts RO, Kantarci K, Geda YE, Knopman DS, Przybelski SA, Weigand SD, Petersen RC, Jack CR Jr (2011) Untreated type 2 diabetes and its complications are associated with subcortical infarctions. Diabetes Care 34(1):184\u2013186","journal-title":"Diabetes Care"},{"issue":"5","key":"5_CR94","doi-asserted-by":"publisher","first-page":"759","DOI":"10.2967\/jnumed.113.132647","volume":"55","author":"RO Roberts","year":"2014","unstructured":"Roberts RO, Knopman DS, Cha RH, Mielke MM, Pankratz VS, Boeve BF, Kantarci K, Geda YE, Jack CR Jr, Petersen RC, Lowe VJ (2014a) Diabetes and elevated hemoglobin a1c levels are associated with brain hypometabolism but not amyloid accumulation. J Nucl Med 55(5):759\u2013764","journal-title":"J Nucl Med"},{"issue":"13","key":"5_CR95","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1212\/WNL.0000000000000269","volume":"82","author":"RO Roberts","year":"2014","unstructured":"Roberts RO, Knopman DS, Przybelski SA, Mielke MM, Kantarci K, Preboske GM, Senjem ML, Pankratz VS, Geda YE, Boeve BF, Ivnik RJ, Rocca WA, Petersen RC, Jack CR (2014b) Association of type 2 diabetes with brain atrophy and cognitive impairment. Neurology 82(13):1132\u20131141","journal-title":"Neurology"},{"issue":"4","key":"5_CR96","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.jstrokecerebrovasdis.2007.03.001","volume":"16","author":"S Saidi","year":"2007","unstructured":"Saidi S, Slamia LB, Ammou SB, Mahjoub T, Almawi WY (2007) Association of apolipoprotein E gene polymorphism with ischemic stroke involving large-vessel disease and its relation to serum lipid levels. J Stroke Cerebrovasc Dis 16(4):160\u2013166","journal-title":"J Stroke Cerebrovasc Dis"},{"issue":"7","key":"5_CR97","doi-asserted-by":"publisher","first-page":"1892","DOI":"10.2337\/db15-1428","volume":"65","author":"M Sajan","year":"2016","unstructured":"Sajan M, Hansen B, Ivey R 3rd, Sajan J, Ari C, Song S, Braun U, Leitges M, Farese-Higgs M, Farese RV (2016) Brain insulin signaling is increased in insulin-resistant states and decreases in FOXOs and PGC-1alpha and increases in Abeta1-40\/42 and Phospho-Tau May Abet Alzheimer development. Diabetes 65(7):1892\u20131903","journal-title":"Diabetes"},{"key":"5_CR98","doi-asserted-by":"publisher","first-page":"64","DOI":"10.3389\/fnagi.2013.00064","volume":"5","author":"N Sato","year":"2013","unstructured":"Sato N, Morishita R (2013) Roles of vascular and metabolic components in cognitive dysfunction of Alzheimer disease: short- and long-term modification by non-genetic risk factors. Front Aging Neurosci 5:64","journal-title":"Front Aging Neurosci"},{"key":"5_CR99","doi-asserted-by":"publisher","first-page":"143","DOI":"10.3389\/fendo.2014.00143","volume":"5","author":"N Sato","year":"2014","unstructured":"Sato N, Morishita R (2014) Brain alterations and clinical symptoms of dementia in diabetes: abeta\/tau-dependent and independent mechanisms. Front Endocrinol (Lausanne) 5:143","journal-title":"Front Endocrinol (Lausanne)"},{"key":"5_CR100","doi-asserted-by":"publisher","first-page":"199","DOI":"10.3389\/fnagi.2015.00199","volume":"7","author":"N Sato","year":"2015","unstructured":"Sato N, Morishita R (2015) The roles of lipid and glucose metabolism in modulation of beta-amyloid, tau, and neurodegeneration in the pathogenesis of Alzheimer disease. Front Aging Neurosci 7:199","journal-title":"Front Aging Neurosci"},{"issue":"2","key":"5_CR101","doi-asserted-by":"publisher","first-page":"118","DOI":"10.2174\/1874609811104020118","volume":"4","author":"N Sato","year":"2011","unstructured":"Sato N, Takeda S, Uchio-Yamada K, Ueda H, Fujisawa T, Rakugi H, Morishita R (2011) Role of insulin signaling in the interaction between Alzheimer disease and diabetes mellitus: a missing link to therapeutic potential. Curr Aging Sci 4(2):118\u2013127","journal-title":"Curr Aging Sci"},{"issue":"1\u20134","key":"5_CR102","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1159\/000334534","volume":"10","author":"N Sato","year":"2012","unstructured":"Sato N, Shinohara M, Rakugi H, Morishita R (2012) Dual effects of statins on Abeta metabolism: upregulation of the degradation of APP-CTF and Abeta clearance. Neurodegener Dis 10(1\u20134):305\u2013308","journal-title":"Neurodegener Dis"},{"issue":"20","key":"5_CR103","doi-asserted-by":"publisher","first-page":"9649","DOI":"10.1073\/pnas.90.20.9649","volume":"90","author":"DE Schmechel","year":"1993","unstructured":"Schmechel DE, Saunders AM, Strittmatter WJ, Crain BJ, Hulette CM, Joo SH, Pericak-Vance MA, Goldgaber D, Roses AD (1993) Increased amyloid beta-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease. Proc Natl Acad Sci U S A 90(20):9649\u20139653","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"5_CR104","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/j.nbd.2009.05.025","volume":"35","author":"L Sereno","year":"2009","unstructured":"Sereno L, Coma M, Rodriguez M, Sanchez-Ferrer P, Sanchez MB, Gich I, Agullo JM, Perez M, Avila J, Guardia-Laguarta C, Clarimon J, Lleo A, Gomez-Isla T (2009) A novel GSK-3beta inhibitor reduces Alzheimer\u2019s pathology and rescues neuronal loss in vivo. Neurobiol Dis 35(3):359\u2013367","journal-title":"Neurobiol Dis"},{"issue":"6","key":"5_CR105","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1016\/S1474-4422(07)70106-0","volume":"6","author":"P Shaw","year":"2007","unstructured":"Shaw P, Lerch JP, Pruessner JC, Taylor KN, Rose AB, Greenstein D, Clasen L, Evans A, Rapoport JL, Giedd JN (2007) Cortical morphology in children and adolescents with different apolipoprotein E gene polymorphisms: an observational study. Lancet Neurol 6(6):494\u2013500","journal-title":"Lancet Neurol"},{"issue":"7673","key":"5_CR106","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1038\/nature24016","volume":"549","author":"Y Shi","year":"2017","unstructured":"Shi Y, Yamada K, Liddelow SA, Smith ST, Zhao L, Luo W, Tsai RM, Spina S, Grinberg LT, Rojas JC, Gallardo G, Wang K, Roh J, Robinson G, Finn MB, Jiang H, Sullivan PM, Baufeld C, Wood MW, Sutphen C, McCue L, Xiong C, Del-Aguila JL, Morris JC, Cruchaga C, Fagan AM, Miller BL, Boxer AL, Seeley WW, Butovsky O, Barres BA, Paul SM, Holtzman DM (2017) ApoE4 markedly exacerbates tau-mediated neurodegeneration in a mouse model of tauopathy. Nature 549(7673):523\u2013527","journal-title":"Nature"},{"key":"5_CR107","doi-asserted-by":"publisher","first-page":"2248","DOI":"10.1016\/j.neurobiolaging.2015.04.002","volume":"36","author":"Y Shibuya","year":"2015","unstructured":"Shibuya Y, Niu Z, Bryleva EY, Harris BT, Murphy SR, Kheirollah A, Bowen ZD, Chang CC, Chang TY (2015) Acyl-coenzyme A:cholesterol acyltransferase 1 blockage enhances autophagy in the neurons of triple transgenic Alzheimer\u2019s disease mouse and reduces human P301L-tau content at the presymptomatic stage. Neurobiol Aging 36:2248\u20132259","journal-title":"Neurobiol Aging"},{"key":"5_CR108","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.neuint.2017.04.020","volume":"108","author":"M Shinohara","year":"2017","unstructured":"Shinohara M, Sato N (2017) Bidirectional interactions between diabetes and Alzheimer\u2019s disease. Neurochem Int 108:296\u2013302","journal-title":"Neurochem Int"},{"issue":"29","key":"5_CR109","doi-asserted-by":"publisher","first-page":"22091","DOI":"10.1074\/jbc.M110.102277","volume":"285","author":"M Shinohara","year":"2010","unstructured":"Shinohara M, Sato N, Kurinami H, Takeuchi D, Takeda S, Shimamura M, Yamashita T, Uchiyama Y, Rakugi H, Morishita R (2010) Reduction of brain \u03b2-amyloid (A\u03b2) by fluvastatin, a hydroxymethylglutaryl-CoA reductase inhibitor, through increase in degradation of amyloid precursor protein C-terminal fragments (APP-CTFs) and A\u03b2 clearance. J Biol Chem 285(29):22091\u201322102","journal-title":"J Biol Chem"},{"issue":"4","key":"5_CR110","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1007\/s00401-013-1086-9","volume":"125","author":"M Shinohara","year":"2013","unstructured":"Shinohara M, Petersen RC, Dickson DW, Bu G (2013) Brain regional correlation of amyloid-beta with synapses and apolipoprotein E in non-demented individuals: potential mechanisms underlying regional vulnerability to amyloid-beta accumulation. Acta Neuropathol 125(4):535\u2013547","journal-title":"Acta Neuropathol"},{"key":"5_CR111","doi-asserted-by":"publisher","first-page":"71","DOI":"10.3389\/fnagi.2014.00071","volume":"6","author":"M Shinohara","year":"2014","unstructured":"Shinohara M, Sato N, Shimamura M, Kurinami H, Hamasaki T, Chatterjee A, Rakugi H, Morishita R (2014) Possible modification of Alzheimer\u2019s disease by statins in midlife: interactions with genetic and non-genetic risk factors. Front Aging Neurosci 6:71","journal-title":"Front Aging Neurosci"},{"issue":"10","key":"5_CR112","first-page":"24628","volume":"2","author":"M Shinohara","year":"2016","unstructured":"Shinohara M, Kanekiyo T, Yang L, Linthicum D, Fu Y, Price L, Frisch-Daiello JL, Han X, Fryer JD, Bu G (2016a) APOE2 eases cognitive decline during aging: clinical and preclinical evaluations. Ann Neurol 2(10):24628","journal-title":"Ann Neurol"},{"issue":"2","key":"5_CR113","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1007\/s00401-016-1580-y","volume":"132","author":"M Shinohara","year":"2016","unstructured":"Shinohara M, Murray ME, Frank RD, DeTure M, Yamazaki Y, Tachibana M, Atagi Y, Davis MD, Liu CC, Zhao N, Painter MM, Petersen RC, Fryer JD, Crook JE, Dickson DW, Bu G, Kanekiyo T (2016b) Impact of sex and APOE4 on cerebral amyloid angiopathy in Alzheimer\u2019s disease. Acta Neuropathol 132(2):225\u2013234","journal-title":"Acta Neuropathol"},{"issue":"7","key":"5_CR115","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1194\/jlr.R075796","volume":"58","author":"M Shinohara","year":"2017","unstructured":"Shinohara M, Tachibana M, Kanekiyo T, Bu G (2017) Role of LRP1 in the pathogenesis of Alzheimer\u2019s disease: evidence from clinical and preclinical studies. J Lipid Res 58(7):1267\u20131281","journal-title":"J Lipid Res"},{"issue":"5","key":"5_CR116","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1111\/j.1471-4159.2010.07079.x","volume":"116","author":"AO Sodero","year":"2011","unstructured":"Sodero AO, Trov\u00f2 L, Iannilli F, Van Veldhoven P, Dotti CG, Martin MG (2011) Regulation of tyrosine kinase B activity by the Cyp46\/cholesterol loss pathway in mature hippocampal neurons: relevance for neuronal survival under stress and in aging. J Neurochem 116(5):747\u2013755","journal-title":"J Neurochem"},{"issue":"9","key":"5_CR117","doi-asserted-by":"publisher","first-page":"e1001087","DOI":"10.1371\/journal.pgen.1001087","volume":"6","author":"O Sofola","year":"2010","unstructured":"Sofola O, Kerr F, Rogers I, Killick R, Augustin H, Gandy C, Allen MJ, Hardy J, Lovestone S, Partridge L (2010) Inhibition of GSK-3 ameliorates Abeta pathology in an adult-onset drosophila model of Alzheimer\u2019s disease. PLoS Genet 6(9):e1001087","journal-title":"PLoS Genet"},{"issue":"1","key":"5_CR118","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.neulet.2009.06.073","volume":"462","author":"A Solomon","year":"2009","unstructured":"Solomon A, Leoni V, Kivipelto M, Besga A, \u00d6kseng\u00e5rd AR, Julin P, Svensson L, Wahlund L-O, Andreasen N, Winblad B, Soininen H, Bj\u00f6rkhem I (2009) Plasma levels of 24S-hydroxycholesterol reflect brain volumes in patients without objective cognitive impairment but not in those with Alzheimer\u2019s disease. Neurosci Lett 462(1):89\u201393","journal-title":"Neurosci Lett"},{"issue":"12","key":"5_CR119","doi-asserted-by":"publisher","first-page":"1842","DOI":"10.4161\/auto.21861","volume":"8","author":"SM Son","year":"2012","unstructured":"Son SM, Song H, Byun J, Park KS, Jang HC, Park YJ, Mook-Jung I (2012) Accumulation of autophagosomes contributes to enhanced amyloidogenic APP processing under insulin-resistant conditions. Autophagy 8(12):1842","journal-title":"Autophagy"},{"issue":"1","key":"5_CR120","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1006\/exnr.1994.1044","volume":"126","author":"DL Sparks","year":"1994","unstructured":"Sparks DL, Scheff SW, Hunsaker JC 3rd, Liu H, Landers T, Gross DR (1994) Induction of Alzheimer-like beta-amyloid immunoreactivity in the brains of rabbits with dietary cholesterol. Exp Neurol 126(1):88\u201394","journal-title":"Exp Neurol"},{"issue":"1","key":"5_CR121","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1148\/radiol.2015142488","volume":"278","author":"RN Srinivasa","year":"2015","unstructured":"Srinivasa RN, Rossetti HC, Gupta MK, Rosenberg RN, Weiner MF, Peshock RM, McColl RW, Hynan LS, Lucarelli RT, King KS (2015) Cardiovascular risk factors associated with smaller brain volumes in regions identified as early predictors of cognitive decline. Radiology 278(1):198\u2013204","journal-title":"Radiology"},{"issue":"6330","key":"5_CR122","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1038\/352073a0","volume":"352","author":"XJ Sun","year":"1991","unstructured":"Sun XJ, Rothenberg P, Kahn CR, Backer JM, Araki E, Wilden PA, Cahill DA, Goldstein BJ, White MF (1991) Structure of the insulin receptor substrate IRS-1 defines a unique signal transduction protein. Nature 352(6330):73\u201377","journal-title":"Nature"},{"issue":"10 Pt 2","key":"5_CR123","doi-asserted-by":"publisher","first-page":"2878","DOI":"10.1016\/j.neubiorev.2013.10.010","volume":"37","author":"S Suri","year":"2013","unstructured":"Suri S, Heise V, Trachtenberg AJ, Mackay CE (2013) The forgotten APOE allele: a review of the evidence and suggested mechanisms for the protective effect of APOE varepsilon2. Neurosci Biobehav Rev 37(10 Pt 2):2878\u20132886","journal-title":"Neurosci Biobehav Rev"},{"issue":"1","key":"5_CR124","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1042\/bj2960015","volume":"296","author":"C Sutherland","year":"1993","unstructured":"Sutherland C, Leighton IA, Cohen P (1993) Inactivation of glycogen synthase kinase-3<em>\u03b2<\/em> by phosphorylation: new kinase connections in insulin and growth-factor signalling. Biochem J 296(1):15\u201319","journal-title":"Biochem J"},{"issue":"8","key":"5_CR125","doi-asserted-by":"publisher","first-page":"5914","DOI":"10.1074\/jbc.M112.442103","volume":"288","author":"LM Tai","year":"2013","unstructured":"Tai LM, Bilousova T, Jungbauer L, Roeske SK, Youmans KL, Yu C, Poon WW, Cornwell LB, Miller CA, Vinters HV, Van Eldik LJ, Fardo DW, Estus S, Bu G, Gylys KH, Ladu MJ (2013) Levels of soluble apolipoprotein E\/amyloid-beta (Abeta) complex are reduced and oligomeric Abeta increased with APOE4 and Alzheimer disease in a transgenic mouse model and human samples. J Biol Chem 288(8):5914\u20135926","journal-title":"J Biol Chem"},{"issue":"15","key":"5_CR126","doi-asserted-by":"publisher","first-page":"7036","DOI":"10.1073\/pnas.1000645107","volume":"107","author":"S Takeda","year":"2010","unstructured":"Takeda S, Sato N, Uchio-Yamada K, Sawada K, Kunieda T, Takeuchi D, Kurinami H, Shinohara M, Rakugi H, Morishita R (2010) Diabetes-accelerated memory dysfunction via cerebrovascular inflammation and Abeta deposition in an Alzheimer mouse model with diabetes. Proc Natl Acad Sci U S A 107(15):7036\u20137041","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"5_CR127","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1172\/JCI59903","volume":"122","author":"K Talbot","year":"2012","unstructured":"Talbot K, Wang HY, Kazi H, Han LY, Bakshi KP, Stucky A, Fuino RL, Kawaguchi KR, Samoyedny AJ, Wilson RS, Arvanitakis Z, Schneider JA, Wolf BA, Bennett DA, Trojanowski JQ, Arnold SE (2012) Demonstrated brain insulin resistance in Alzheimer\u2019s disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline. J Clin Invest 122(4):1316\u20131338","journal-title":"J Clin Invest"},{"issue":"11","key":"5_CR128","doi-asserted-by":"publisher","first-page":"2616","DOI":"10.1161\/01.STR.31.11.2616","volume":"31","author":"Y Tanizaki","year":"2000","unstructured":"Tanizaki Y, Kiyohara Y, Kato I, Iwamoto H, Nakayama K, Shinohara N, Arima H, Tanaka K, Ibayashi S, Fujishima M (2000) Incidence and risk factors for subtypes of cerebral infarction in a general population: the Hisayama study. Stroke 31(11):2616\u20132622","journal-title":"Stroke"},{"issue":"1","key":"5_CR129","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1111\/j.1447-0594.2012.00880.x","volume":"13","author":"N Tomita","year":"2013","unstructured":"Tomita N, Furukawa K, Okamura N, Tashiro M, Une K, Furumoto S, Iwata R, Yanai K, Kudo Y, Arai H (2013) Brain accumulation of amyloid beta protein visualized by positron emission tomography and BF-227 in Alzheimer\u2019s disease patients with or without diabetes mellitus. Geriatr Gerontol Int 13(1):215\u2013221","journal-title":"Geriatr Gerontol Int"},{"issue":"11","key":"5_CR130","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1212\/WNL.0b013e3181f25f06","volume":"75","author":"SGC Elderen van","year":"2010","unstructured":"van Elderen SGC, de Roos A, de Craen AJM, Westendorp RGJ, Blauw GJ, Jukema JW, Bollen ELEM, Middelkoop HAM, van Buchem MA, van der Grond J (2010) Progression of brain atrophy and cognitive decline in diabetes mellitus: a 3-year follow-up. Neurology 75(11):997\u20131002","journal-title":"Neurology"},{"issue":"2","key":"5_CR131","first-page":"2011","volume":"30","author":"P Vliet van","year":"2012","unstructured":"van Vliet P (2012) Cholesterol and late-life cognitive decline. J Alzheimers Dis 30(2):2011\u2013111028","journal-title":"J Alzheimers Dis"},{"issue":"5","key":"5_CR132","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1523\/JNEUROSCI.20-05-01657.2000","volume":"20","author":"K Vekrellis","year":"2000","unstructured":"Vekrellis K, Ye Z, Qiu WQ, Walsh D, Hartley D, Chesneau V, Rosner MR, Selkoe DJ (2000) Neurons regulate extracellular levels of amyloid beta-protein via proteolysis by insulin-degrading enzyme. J Neurosci 20(5):1657\u20131665","journal-title":"J Neurosci"},{"issue":"3","key":"5_CR133","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/S1474-4422(10)70325-2","volume":"10","author":"PB Verghese","year":"2011","unstructured":"Verghese PB, Castellano JM, Holtzman DM (2011) Apolipoprotein E in Alzheimer\u2019s disease and other neurological disorders. Lancet Neurol 10(3):241\u2013252","journal-title":"Lancet Neurol"},{"issue":"19","key":"5_CR134","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1073\/pnas.1220484110","volume":"110","author":"PB Verghese","year":"2013","unstructured":"Verghese PB, Castellano JM, Garai K, Wang Y, Jiang H, Shah A, Bu G, Frieden C, Holtzman DM (2013) ApoE influences amyloid-beta (Abeta) clearance despite minimal apoE\/Abeta association in physiological conditions. Proc Natl Acad Sci U S A 110(19):25","journal-title":"Proc Natl Acad Sci U S A"},{"key":"5_CR135","doi-asserted-by":"publisher","first-page":"2329","DOI":"10.1212\/WNL.0000000000001655","volume":"84","author":"G Weinstein","year":"2015","unstructured":"Weinstein G, Maillard P, Himali JJ, Beiser AS, Au R, Wolf PA, Seshadri S, DeCarli C (2015) Glucose indices are associated with cognitive and structural brain measures in young adults. Neurology 84:2329\u20132337","journal-title":"Neurology"},{"issue":"15","key":"5_CR136","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1001\/jama.2009.460","volume":"301","author":"RA Whitmer","year":"2009","unstructured":"Whitmer RA, Karter AJ, Yaffe K, Quesenberry CP Jr, Selby JV (2009) Hypoglycemic episodes and risk of dementia in older patients with type 2 diabetes mellitus. JAMA 301(15):1565\u20131572","journal-title":"JAMA"},{"issue":"6","key":"5_CR137","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1136\/jnnp.73.6.672","volume":"73","author":"RS Wilson","year":"2002","unstructured":"Wilson RS, Bienias JL, Berry-Kravis E, Evans DA, Bennett DA (2002) The apolipoprotein E epsilon 2 allele and decline in episodic memory. J Neurol Neurosurg Psychiatry 73(6):672\u2013677","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"14","key":"5_CR138","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1001\/jamainternmed.2013.6176","volume":"173","author":"K Yaffe","year":"2013","unstructured":"Yaffe K, Falvey CM, Hamilton N, Harris TB, Simonsick EM, Strotmeyer ES, Shorr RI, Metti A, Schwartz AV (2013) Association between hypoglycemia and dementia in a biracial cohort of older adults with diabetes mellitus. JAMA Intern Med 173(14):1300\u20131306","journal-title":"JAMA Intern Med"},{"issue":"1","key":"5_CR139","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.neuron.2017.09.003","volume":"96","author":"N Zhao","year":"2017","unstructured":"Zhao N, Liu CC, Van Ingelgom AJ, Martens YA, Linares C, Knight JA, Painter MM, Sullivan PM, Bu G (2017) Apolipoprotein E4 impairs neuronal insulin signaling by trapping insulin receptor in the endosomes. Neuron 96(1):115\u2013129.e115","journal-title":"Neuron"},{"issue":"4","key":"5_CR140","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.biopsych.2017.03.003","volume":"83","author":"Na Zhao","year":"2018","unstructured":"Zhao N, Liu CC, QiaoW Bu G (2018) Apolipoprotein E, receptors, and modulation of Alzheimer\u2019s disease. Biol Psychiat 83(4):347\u2013357","journal-title":"Biological Psychiatry"}],"container-title":["Advances in Experimental Medicine and Biology","Diabetes Mellitus"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-981-13-3540-2_5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,17]],"date-time":"2024-07-17T18:05:25Z","timestamp":1721239525000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-981-13-3540-2_5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"ISBN":["9789811335396","9789811335402"],"references-count":139,"URL":"https:\/\/doi.org\/10.1007\/978-981-13-3540-2_5","relation":{},"ISSN":["0065-2598","2214-8019"],"issn-type":[{"value":"0065-2598","type":"print"},{"value":"2214-8019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019]]},"assertion":[{"value":"7 May 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}